Other OTC • Healthcare • Biotechnology • FR • USD
Cellectis S.A. (CMVLF) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 7 recommend buying, 2 recommend holding, and 1 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
